20/20 Biolabs, Inc.’s Q3 2026 10-Q window runs Nov 9, 2026 to Nov 25, 2026.
Based on 2 prior 10-Q filings.
20/20 Biolabs, Inc. · CIK 1139685 · Engraved from SEC EDGAR
